CCMB and Apollo Hospitals Collaborate to Manufacture Dry Swab Testing Kits

CSIR-CCMB has developed rapid, safe, and cost-effective DArRT-PCR tests, and the collaboration with Apollo Hospitals will focus on scaling up manufacturing and commercialization of the tests jointly.

CSIR-Centre for Cellular & Molecular Biology (CCMB) and Apollo Hospitals announced a collaboration for joint manufacturing and commercialization of an innovative dry swab test for SARS-CoV-2 detection.

Direct Amplification rapid RT-PCR (DArRT-PCR) has been developed by CSIR-CCMB, and the collaboration with Apollo Hospitals will focus on scaling up manufacturing and commercialization of the tests jointly.

Potential Weaknesses in SARS-CoV-2 Infection Discovered
Transmembrane protein TMEM41B was essential for SARS-CoV-2 to replicate, said researchers.

‘CSIR-CCMB has developed rapid, safe, and cost-effective DArRT-PCR tests, and the collaboration with Apollo Hospitals will focus on scaling up manufacturing and commercialization of the dry swab tests jointly. ’

The rapid, safe, and cost-effective DArRT-PCR tests will be available nationally through the Apollo Hospitals network, a joint statement said.

The sample collection centers can send dry nasal or oropharyngeal swabs to testing centers with no need for the imported and expensive Viral Transport Medium. The biological sample can be directly isolated from the patient swabs and testing using a one-step protocol.

The current gold-standard method requires many expensive reagents and steps that add to the expertise, money, and time required for the tests. The DArRT-PCR test reduces the time and human effort by 40-50 percent in the current setting of testing.

Sputum Testing Has a Higher Rate of SARS-CoV-2 Detection
Sputum testing is more accurate compared to the swab testing and provided a higher rate of COVID-19 detection, reveals a new study.

"As people are getting back to their normal lives and businesses, it is important for us to ramp up our testing for the coronavirus. The virus will be here for some time, it seems, and those who test more frequently will be able to contain the impact of COVID-19 better," said Rakesh Mishra, Director, CSIR-CCMB.

He said that cheaper, rapid, and easy to use tests are the need of the hour.

Embryos Could be Susceptible to SARS-CoV-2 Virus
Genes that are thought to play a role in how the SARS-CoV-2 virus infects our cells have been found to be active in embryos as early as during the second week of pregnancy, said scientists.

"These tests will give a boost to the efforts to mitigate the effect of Covid-19 and will play a major role in controlling the pandemic," said Sangita Reddy, Joint Managing Director, Apollo Hospitals Group.

New Test Helps Reveal Data on Immune Response to Sars-Cov-2 Following Organ Transplantation
A new test that provides information on the immune response to the novel coronavirus in patients who need to take immunosuppressive drugs has been developed.

Source-IANS